Detalles de la búsqueda
1.
SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?
Mod Pathol
; 37(2): 100405, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104893
2.
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.
J Immunol
; 208(12): 2847-2855, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595309
3.
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Lancet Oncol
; 23(3): 406-415, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35074072
4.
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.
Mol Cancer
; 21(1): 185, 2022 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36163179
5.
Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments.
Am J Hematol
; 97(5): 638-656, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35266562
6.
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma-Finding a Dancing Partner.
Curr Oncol Rep
; 24(10): 1299-1311, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35596920
7.
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
Curr Treat Options Oncol
; 23(11): 1614-1625, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36227407
8.
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma.
Mod Pathol
; 34(12): 2183-2191, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376807
9.
MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma.
Haematologica
; 106(5): 1381-1389, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273477
10.
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
Am J Hematol
; 96(2): 241-250, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33180322
11.
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.
J Immunol
; 203(11): 3078-3085, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31645416
12.
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Am J Hematol
; 95(6): 623-629, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32239765
13.
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
Cancer
; 125(4): 559-574, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30508305
14.
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors.
Haematologica
; 109(1): 343-350, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470152
15.
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
Am J Hematol
; 94(6): 710-725, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963600
16.
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Mycoses
; 62(12): 1140-1147, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31520441
17.
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase.
Cancer
; 124(6): 1160-1168, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29266206
18.
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
Br J Haematol
; 180(1): 33-40, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29164608
19.
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
Br J Haematol
; 182(3): 404-411, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29785709
20.
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.
Br J Haematol
; 183(4): 578-587, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30175400